Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial

Journal of Child Neurology

Volumn 22, Issue 10, 2007, Pages 1191-1197

  Mehta, Vishal ^a   Singhi, Pratibha ^a   Singhi, Sunit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Continuous diazepam infusion; Intravenous sodium valproate; Refractory status epilepticus

Indexed keywords

DIAZEPAM; HYPERTENSIVE FACTOR; INOTROPIC AGENT; THIOPENTAL; VALPROIC ACID; ANTICONVULSIVE AGENT; VASOCONSTRICTOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EPILEPTIC STATE; HUMAN; HYPOTENSION; INFANT; LIVER FUNCTION; LOADING DRUG DOSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SIDE EFFECT; SINGLE DRUG DOSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRESCHOOL CHILD; RESPIRATORY FAILURE; STATISTICS; TIME; TREATMENT OUTCOME;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DIAZEPAM; FEMALE; HUMANS; HYPOTENSION; INFANT; INFUSIONS, INTRAVENOUS; MALE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; STATUS EPILEPTICUS; TIME FACTORS; TREATMENT OUTCOME; VALPROIC ACID; VASOCONSTRICTOR AGENTS;

EID: 34547881203     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807306248     Document Type: Article

References (29)

1. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996; 46:1029-1035.
2. Chin RF, Neville BG, Peckham C., Bedford H., et al; NLSTEPSS Collaborative Group. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study. Lancet. 2006; 368:222-229.
3. Garzon E., Fernandes RM, Sakamoto AC Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure. 2003; 12:337-345.
4. Gilbert DL, Gartside PS, Glauser TA Efficacy and mortality in treatment of refractory generalised convulsive status epilepticus in children: A meta-analysis. J Child Neurol. 1999; 14:602-609.
5. Metsaranta P., Koivikko M., Peltola J., Eriksson K. Outcome after prolonged convulsive seizures in 186 children: Low morbidity, no mortality. Dev Med Child Neurol. 2004; 46:4-8.
6. Eriksson K., Metsaranta P., Huhtala H., Auvinen A., et al. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005; 65:1316-1318.
7. Kalviainen R., Eriksson K., Parviainen I. Refractory generalised convulsive status epilepticus: A guide to treatment. CNS Drugs. 2005; 19:759-768.
8. Singhi S., Singhi P., Dass R. Status epilepticus: Emergency management. Indian J Pediatr. 2003: 70:S17-22.
9. Lowenstein DH, Alldredge BK Status epilepticus. N Engl J Med. 1998; 338:970-976.
10. Singhi S., Banerjee S., Singhi P. Refractory status epilepticus in children: Role of continuous diazepam infusion. J Child Neurol. 1998; 13:23-26.
11. Singhi S., Murthy A., Singhi P., Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002; 17:106-110.
12. Ozdemir D., Gulez P., Uran N., Yendur G., et al. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure. 2005; 14:129-132.
13. Lee WK, Liu KT, Young BW Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol. 2006; 34:63-65.
14. Parviainen I., Uusaro A., Kalviainen R., Kaukanen E., et al. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology. 2002; 22:1249-1251.
15. Claassen J., Hirsch LJ, Emerson RG, Mayer SA Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia. 2002; 43:146-153.
16. Van Gestel JP, Malingre M., Ververs FF, Braun KP, et al. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005; 65:591-592.
17. Honack D., Loscher W. Intravenous valproate: Onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and Phenytoin. Epilepsy Res. 1992; 13:215-221.
18. Yamamoto LG, Yim GK The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care. 2000; 16:296-298.
19. Uberall MA, Trollmann R., Wunsiedler U., Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology. 2000; 54:2188-2189.
20. Yu KT, Mills S., Thompson N., Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003; 44:724-726.
21. Campistol J., Fernandez A., Ortega J. Status epilepticus in children. Experience with intravenous valproate: Update of treatment guidelines (in Spanish). RevNeurol. 1999;29:359-365.
22. Jha S., Jose M., Patel R. Intravenous sodium valproate in status epilepticus. Neurol India. 2003; 51:421-422.
23. Peters Cna, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-experience in 102 adult patients. Seizure. 2005; 14:164-169.
24. Limdi NA, Shimpi AV, Faught E., Gomez CR, Burneo JG Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. 2005; 64:353-355.
25. Ramsay RE, Cantrell D., Collins SD, Naritoku DK, et al. Safety and tolerance of rapidly infused valproic acid. A randomized trial in subjects with epilepsy. Epilepsy Res. 2003; 52:189-201.
26. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, et al. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology. 2004; 63:1507-1508.
27. Allarakhia IN, Garofalo EA, Komarynski MA, Robertson PL. Valproic acid and thrombocytopenia in children: A case-controlled retrospective study. Pediatr Neurol. 1996; 14:303-307.
28. Anderson GD, Temkin NR, Chandler WL, Winn HR Effect of valproate on haemostatic function in patients with traumatic brain injury. Epilepsy Res. 2003; 57:111-119.
29. Gerstner T., Teich M., Bell N., Longin E., et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006; 47:1136-1143.